Mitochondrial dynamics: Orchestrating the journey to advanced age

Journal of Molecular and Cellular Cardiology

Volumn 83, Issue , 2015, Pages 37-43

  Biala, Agnieszka K ^a   Dhingra, Rimpy ^b   Kirshenbaum, Lorrie A ^b  

^a ST BONIFACE GENERAL HOSPITAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

Author keywords

Aging; Cell death; Mitochondrial dynamics; Oxidative stress; ROS

Indexed keywords

CYCLOPHILIN D; DNA DIRECTED DNA POLYMERASE GAMMA; MITOCHONDRIAL DNA; PROTEIN P53; SIRTUIN 3; UBIQUITIN; MITOCHONDRIAL PROTEIN; SIRTUIN;

AGING; AUTOPHAGY; BIOGENESIS; CALORIC RESTRICTION; CARDIOVASCULAR FUNCTION; CELL METABOLISM; CELL ORGANELLE; CELL RESPIRATION; DEACETYLATION; DNA REPAIR; DNA REPLICATION; ELECTRON TRANSPORT; HETEROZYGOSITY; HUMAN; IMMUNOREGULATION; LIFESPAN; LONGEVITY; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; MITOPHAGY; MOLECULAR DYNAMICS; MOLECULAR EVOLUTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; CELL DEATH; GENE EXPRESSION REGULATION; GENETICS; HEART FAILURE; HEART MUSCLE; METABOLISM; MITOCHONDRIAL DYNAMICS; PATHOLOGY;

AGING; ANIMALS; CALORIC RESTRICTION; CELL DEATH; GENE EXPRESSION REGULATION; HEART FAILURE; HUMANS; MITOCHONDRIA; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL PROTEINS; MYOCARDIUM; OXIDATIVE STRESS; SIGNAL TRANSDUCTION; SIRTUINS;

EID: 84937969345     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2015.04.015     Document Type: Review

References (108)

1. Kovacic J.C., Moreno P., Hachinski V., Nabel E.G., Fuster V. Cellular senescence, vascular disease, and aging: part 1 of a 2-part review. Circulation 2011, 123:1650-1660.
2. Basso E., Fante L., Fowlkes J., Petronilli V., Forte M.A., Bernardi P. Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem 2005, 280:18558-18561.
3. Minamino T., Miyauchi H., Yoshida T., Ishida Y., Yoshida H., Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 2002, 105:1541-1544.
4. Voghel G., Thorin-Trescases N., Farhat N., Nguyen A., Villeneuve L., Mamarbachi A.M., et al. Cellular senescence in endothelial cells from atherosclerotic patients is accelerated by oxidative stress associated with cardiovascular risk factors. Mech Ageing Dev 2007, 128:662-671.
5. Kirshenbaum L.A., Singal P.K. Antioxidant changes in heart hypertrophy: significance during hypoxia-reoxygenation injury. Can J Physiol Pharmacol 1992, 70:1330-1335.
6. McCord J.M. Superoxide radical: controversies, contradictions, and paradoxes [see comments]. Proc Soc Exp Biol Med 1995, 209:112-117.
7. Fridovich I., Freeman B. Antioxidant defenses in the lung. Annu Rev Physiol 1986, 48:693-702.
8. Richter C., Gogvadze V., Laffranchi R., Schlapbach R., Schweizer M., Suter M., et al. Oxidants in mitochondria: from physiology to diseases. Biochim Biophys Acta 1995, 1271:67-74.
9. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol Rev 1999, 79:1127-1155.
10. Min L., Jian-xing X. Detoxifying function of cytochrome c against oxygen toxicity. Mitochondrion 2007, 7:13-16.
11. Cortial S., Chaignon P., Iorga B.I., Aymerich S., Truan G., Gueguen-Chaignon V., et al. NADH oxidase activity of Bacillus subtilis nitroreductase NfrA1: insight into its biological role. FEBS Lett 2010, 584:3916-3922.
12. Naoi M., Maruyama W., Inaba-Hasegawa K. Type A and B monoamine oxidase in age-related neurodegenerative disorders: their distinct roles in neuronal death and survival. Curr Top Med Chem 2012, 12:2177-2188.
13. Zorov D.B., Juhaszova M., Sollott S.J. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev 2014, 94:909-950.
14. Feuerstein G., Yue T.L., Ma X., Ruffolo R.R. Novel mechanisms in the treatment of heart failure: inhibition of oxygen radicals and apoptosis by carvedilol. Prog Cardiovasc Dis 1998, 41:17-24.
15. Singal P.K., Li T., Kumar D., Danelisen I., Iliskovic N. Adriamycin-induced heart failure: mechanism and modulation. Mol Cell Biochem 2000, 207:77-86.
16. Singal P.K., Kirshenbaum L.A. A relative deficit in antioxidant reserve may contribute in cardiac failure. Can J Cardiol 1990, 6:47-49.
17. Giordano F.J. Oxygen, oxidative stress, hypoxia, and heart failure. J Clin Invest 2005, 115:500-508.
18. Harman D. Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 2006, 1067:10-21.
19. Das K.C., Muniyappa H. Age-dependent mitochondrial energy dynamics in the mice heart: role of superoxide dismutase-2. Exp Gerontol 2013, 48:947-959.
20. Schriner S.E., Linford N.J., Martin G.M., Treuting P., Ogburn C.E., Emond M., et al. Extension of murine life span by overexpression of catalase targeted to mitochondria. Science 2005, 308:1909-1911.
21. Zhao K., Zhao G.M., Wu D., Soong Y., Birk A.V., Schiller P.W., et al. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 2004, 279:34682-34690.
22. Dai D.F., Rabinovitch P.S., Ungvari Z. Mitochondria and cardiovascular aging. Circ Res 2012, 110:1109-1124.
23. Chiara F., Castellaro D., Marin O., Petronilli V., Brusilow W.S., Juhaszova M., et al. Hexokinase II detachment from mitochondria triggers apoptosis through the permeability transition pore independent of voltage-dependent anion channels. PLoS One 2008, 3. e1852.
24. Dorn G.W., Kitsis R.N. The mitochondrial dynamism-mitophagy-cell death interactome: multiple roles performed by members of a mitochondrial molecular ensemble. Circ Res 2015, 116:167-182.
25. Chen H., Chomyn A., Chan D.C. Disruption of fusion results in mitochondrial heterogeneity and dysfunction. J Biol Chem 2005, 280:26185-26192.
26. Jimenez R.E., Kubli D.A., Gustafsson AB Autophagy and mitophagy in the myocardium: therapeutic potential and concerns. Br J Pharmacol 2014, 171:1907-1916.
27. Pohjoismaki J.L., Boettger T., Liu Z., Goffart S., Szibor M., Braun T. Oxidative stress during mitochondrial biogenesis compromises mtDNA integrity in growing hearts and induces a global DNA repair response. Nucleic Acids Res 2012, 40:6595-6607.
28. Das S., Mitrovsky G., Vasanthi H.R., Das D.K. Antiaging properties of a grape-derived antioxidant are regulated by mitochondrial balance of fusion and fission leading to mitophagy triggered by a signaling network of Sirt1-Sirt3-Foxo3-PINK1-PARKIN. Oxid Med Cell Longev 2014, 2014:345105.
29. Mughal W., Dhingra R., Kirshenbaum L.A. Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart. Curr Hypertens Rep 2012, 14:540-547.
30. Wang E.Y., Gang H., Aviv Y., Dhingra R., Margulets V., Kirshenbaum L.A. p53 mediates autophagy and cell death by a mechanism contingent on Bnip3. Hypertension 2013, 62:70-77.
31. Dhingra R., Kirshenbaum L.A. Mst-1 switches between cardiac cell life and death. Nat Med 2013, 19:1367-1368.
32. Weidman D., Shaw J., Bednarczyk J., Regula K.M., Yurkova N., Zhang T., et al. Dissecting apoptosis and intrinsic death pathways in the heart. Methods Enzymol 2008, 446:277-285.
33. Trifunovic A., Wredenberg A., Falkenberg M., Spelbrink J.N., Rovio A.T., Bruder C.E., et al. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 2004, 429:417-423.
34. Haendeler J., Hoffmann J., Diehl J.F., Vasa M., Spyridopoulos I., Zeiher A.M., et al. Antioxidants inhibit nuclear export of telomerase reverse transcriptase and delay replicative senescence of endothelial cells. Circ Res 2004, 94:768-775.
35. Wei Y.H., Wu S.B., Ma Y.S., Lee H.C. Respiratory function decline and DNA mutation in mitochondria, oxidative stress and altered gene expression during aging. Chang Gung Med J 2009, 32:113-132.
36. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
37. Trifunovic A., Hansson A., Wredenberg A., Rovio A.T., Dufour E., Khvorostov I., et al. Somatic mtDNA mutations cause aging phenotypes without affecting reactive oxygen species production. Proc Natl Acad Sci U S A 2005, 102:17993-17998.
38. Zhang D., Mott J.L., Chang S.W., Denniger G., Feng Z., Zassenhaus H.P. Construction of transgenic mice with tissue-specific acceleration of mitochondrial DNA mutagenesis. Genomics 2000, 69:151-161.
39. Kraytsberg Y., Nekhaeva E., Bodyak N.B., Khrapko K. Mutation and intracellular clonal expansion of mitochondrial genomes: two synergistic components of the aging process?. Mech Ageing Dev 2003, 124:49-53.
40. Ishihara T., Ban-Ishihara R., Maeda M., Matsunaga Y., Ichimura A., Kyogoku S., et al. Dynamics of mitochondrial DNA nucleoids regulated by mitochondrial fission is essential for maintenance of homogeneously active mitochondria during neonatal heart development. Mol Cell Biol 2015, 35:211-223.
41. Katada S., Mito T., Ogasawara E., Hayashi J., Nakada K. Mitochondrial DNA with a large-scale deletion causes two distinct mitochondrial disease phenotypes in mice. G3 (Bethesda) 2013, 3:1545-1552.
42. Tam Z.Y., Gruber J., Halliwell B., Gunawan R. Mathematical modeling of the role of mitochondrial fusion and fission in mitochondrial DNA maintenance. PLoS One 2013, 8:e76230.
43. Leri A., Malhotra A., Liew C.C., Kajstura J., Anversa P. Telomerase activity in rat cardiac myocytes is age and gender dependent. J Mol Cell Cardiol 2000, 32:385-390.
44. Rhyu M.S. Telomeres, telomerase, and immortality [see comments]. J Natl Cancer Inst 1995, 87:884-894.
45. Sussman M.A., Anversa P. Myocardial aging and senescence: where have the stem cells gone?. Annu Rev Physiol 2004, 66:29-48.
46. Bhayadia R., Schmidt B.M., Melk A., Homme M. Senescence-Induced Oxidative Stress Causes Endothelial Dysfunction. J Gerontol A Biol Sci Med Sci 2015, 3.
47. Chen J., Huang X., Halicka D., Brodsky S., Avram A., Eskander J., et al. Contribution of p16INK4a and p21CIP1 pathways to induction of premature senescence of human endothelial cells: permissive role of p53. Am J Physiol Heart Circ Physiol 2006, 290:H1575-H1586.
48. Holdt L.M., Sass K., Gabel G., Bergert H., Thiery J., Teupser D. Expression of Chr9p21 genes CDKN2B (p15(INK4b)), CDKN2A (p16(INK4a), p14(ARF)) and MTAP in human atherosclerotic plaque. Atherosclerosis 2011, 214:264-270.
49. Serrano M., Lee H., Chin L., Cordon-Cardo C., Beach D., DePinho R.A. Role of the INK4a locus in tumor suppression and cell mortality. Cell 1996, 85:27-37.
50. Wei W., Hemmer R.M., Sedivy J.M. Role of p14(ARF) in replicative and induced senescence of human fibroblasts. Mol Cell Biol 2001, 21:6748-6757.
51. Westhoff J.H., Hilgers K.F., Steinbach M.P., Hartner A., Klanke B., Amann K., et al. Hypertension induces somatic cellular senescence in rats and humans by induction of cell cycle inhibitor p16INK4a. Hypertension 2008, 52:123-129.
52. Cesselli D., Beltrami A.P., D'Aurizio F., Marcon P., Bergamin N., Toffoletto B., et al. Effects of age and heart failure on human cardiac stem cell function. Am J Pathol 2011, 179:349-366.
53. Leri A., Franco S., Zacheo A., Barlucchi L., Chimenti S., Limana F., et al. Ablation of telomerase and telomere loss leads to cardiac dilatation and heart failure associated with p53 upregulation. EMBO J 2003, 22:131-139.
54. Chang E., Harley C.B. Telomere length and replicative aging in human vascular tissues. Proc Natl Acad Sci U S A 1995, 92:11190-11194.
55. Heilbronn L.K., Ravussin E. Calorie restriction and aging: review of the literature and implications for studies in humans. Am J Clin Nutr 2003, 78:361-369.
56. Haigis M.C., Guarente L.P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev 2006, 20:2913-2921.
57. Rohrbach S., Aslam M., Niemann B., Schulz R. Impact of caloric restriction on myocardial ischaemia/reperfusion injury and new therapeutic options to mimic its effects. Br J Pharmacol 2014, 171:2964-2992.
58. Ghosh H.S. The anti-aging, metabolism potential of SIRT1. Curr Opin Investig Drugs 2008, 9:1095-1102.
59. Chen D., Steele A.D., Hutter G., Bruno J., Govindarajan A., Easlon E., et al. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol 2008, 43:1086-1093.
60. Chen D., Bruno J., Easlon E., Lin S.J., Cheng H.L., Alt F.W., et al. Tissue-specific regulation of SIRT1 by calorie restriction. Genes Dev 2008, 22:1753-1757.
61. Jadiya P., Chatterjee M., Sammi S.R., Kaur S., Palit G., Nazir A. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease. Biochem Biophys Res Commun 2011, 413:306-310.
62. Luo X.Y., Qu S.L., Tang Z.H., Zhang Y., Liu M.H., Peng J., et al. SIRT1 in cardiovascular aging. Clin Chim Acta 2014, 437:106-114.
63. Morris B.J. Seven sirtuins for seven deadly diseases of aging. Free Radic Biol Med 2013, 56:133-171.
64. Nogueiras R., Habegger K.M., Chaudhary N., Finan B., Banks A.S., Dietrich M.O., et al. Sirtuin 1 and sirtuin 3: physiological modulators of metabolism. Physiol Rev 2012, 92:1479-1514.
65. Fabrizio P., Gattazzo C., Battistella L., Wei M., Cheng C., McGrew K., et al. Sir2 blocks extreme life-span extension. Cell 2005, 123:655-667.
66. Franco S.S., De F.L., Ghaffari S., Brugnara C., Sinclair D.A., Matte' A. Resveratrol accelerates erythroid maturation by activation of FoxO3 and ameliorates anemia in beta-thalassemic mice. Haematologica 2014, 99:267-275.
67. Warboys C.M., de LA Amini N., Luong L., Duckles H., Hsiao S., et al. Disturbed flow promotes endothelial senescence via a p53-dependent pathway. Arterioscler. Thromb. Vasc. Biol. 2014, 34:985-995.
68. Gano L.B., Donato A.J., Pasha H.M., Hearon C.M., Sindler A.L., Seals D.R. The SIRT1 activator SRT1720 reverses vascular endothelial dysfunction, excessive superoxide production, and inflammation with aging in mice. Am J Physiol Heart Circ Physiol 2014, 307:H1754-H1763.
69. Zwerschke W., Mazurek S., Stockl P., Hutter E., Eigenbrodt E., Jansen-Durr P. Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence. Biochem J 2003, 376:403-411.
70. Hahn-Windgassen A., Nogueira V., Chen C.C., Skeen J.E., Sonenberg N., Hay N. Akt activates the mammalian target of rapamycin by regulating cellular ATP level and AMPK activity. J Biol Chem 2005, 280:32081-32089.
71. Wu J.J., Liu J., Chen E.B., Wang J.J., Cao L., Narayan N., et al. Increased mammalian lifespan and a segmental and tissue-specific slowing of aging after genetic reduction of mTOR expression. Cell Rep. 2013, 4:913-920.
72. Dhingra R., Gang H., Wang Y., Biala A.K., Aviv Y., Margulets V., et al. Bidirectional regulation of nuclear factor-kappaB and mammalian target of rapamycin signaling functionally links Bnip3 gene repression and cell survival of ventricular myocytes. Circ Heart Fail 2013, 6:335-343.
73. Atkins K.M., Thomas L.L., Barroso-Gonzalez J., Thomas L., Auclair S., Yin J., et al. The multifunctional sorting protein PACS-2 regulates SIRT1-mediated deacetylation of p53 to modulate p21-dependent cell-cycle arrest. Cell Rep. 2014, 8:1545-1557.
74. Coleman P.R., Chang G., Hutas G., Grimshaw M., Vadas M.A., Gamble J.R. Age-associated stresses induce an anti-inflammatory senescent phenotype in endothelial cells. Aging 2013, 5:913-924.
75. Tanno M., Kuno A., Yano T., Miura T., Hisahara S., Ishikawa S., et al. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 2010, 285:8375-8382.
76. Hafner A.V., Dai J., Gomes A.P., Xiao C.Y., Palmeira C.M., Rosenzweig A., et al. Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy. Aging (Albany NY) 2010, 2:914-923.
77. Porter G.A., Urciuoli W.R., Brookes P.S., Nadtochiy S.M. SIRT3 deficiency exacerbates ischemia-reperfusion injury: implication for aged hearts. Am J Physiol Heart Circ Physiol 2014, 306:H1602-H1609.
78. Dorn G.W., Scorrano L. Two close, too close: sarcoplasmic reticulum-mitochondrial crosstalk and cardiomyocyte fate. Circ Res 2010, 107:689-699.
79. Eschenbacher W.H., Song M., Chen Y., Bhandari P., Zhao P., Jowdy C.C., et al. Two rare human mitofusin 2 mutations alter mitochondrial dynamics and induce retinal and cardiac pathology in Drosophila. PLoS One 2012, 7:e44296.
80. Okamoto K., Shaw J.M. Mitochondrial morphology and dynamics in yeast and multicellular eukaryotes. Annu Rev Genet 2005, 39:503-536.
81. Bossy-Wetzel E., Barsoum M.J., Godzik A., Schwarzenbacher R., Lipton S.A. Mitochondrial fission in apoptosis, neurodegeneration and aging. Curr Opin Cell Biol 2003, 15:706-716.
82. Iglewski M., Hill J.A., Lavandero S., Rothermel B.A. Mitochondrial fission and autophagy in the normal and diseased heart. Curr Hypertens Rep 2010, 12:418-425.
83. Mopert K., Hajek P., Frank S., Chen C., Kaufmann J., Santel A. Loss of Drp1 function alters OPA1 processing and changes mitochondrial membrane organization. Exp Cell Res 2009, 315:2165-2180.
84. James D.I., Parone P.A., Mattenberger Y., Martinou J.C. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 2003, 278:36373-36379.
85. Yoon Y., Krueger E.W., Oswald B.J., McNiven M.A. The mitochondrial protein hFis1 regulates mitochondrial fission in mammalian cells through an interaction with the dynamin-like protein DLP1. Mol Cell Biol 2003, 23:5409-5420.
86. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003, 160:189-200.
87. Chen H., Chan D.C. Physiological functions of mitochondrial fusion. Ann N Y Acad Sci 2010, 1201:21-25.
88. Olichon A., Guillou E., Delettre C., Landes T., Arnaune-Pelloquin L., Emorine L.J., et al. Mitochondrial dynamics and disease, OPA1. Biochim Biophys Acta 1763, 2006:500-509.
89. Ishihara N., Nomura M., Jofuku A., Kato H., Suzuki S.O., Masuda K., et al. Mitochondrial fission factor Drp1 is essential for embryonic development and synapse formation in mice. Nat Cell Biol 2009, 11:958-966.
90. Alavi M.V., Bette S., Schimpf S., Schuettauf F., Schraermeyer U., Wehrl H.F., et al. A splice site mutation in the murine Opa1 gene features pathology of autosomal dominant optic atrophy. Brain 2007, 130:1029-1042.
91. Dorn G.W., Clark C.F., Eschenbacher W.H., Kang M.Y., Engelhard J.T., Warner S.J., et al. MARF and Opa1 control mitochondrial and cardiac function in Drosophila. Circ Res 2011, 108:12-17.
92. Zhao L., Zou X., Feng Z., Luo C., Liu J., Li H., et al. Evidence for association of mitochondrial metabolism alteration with lipid accumulation in aging rats. Exp Gerontol 2014, 56:3-12.
93. Bhandari P., Song M., Chen Y., Burelle Y., Dorn G.W. Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin. Circ Res 2014, 114:257-265.
94. Park Y.Y., Lee S., Karbowski M., Neutzner A., Youle R.J., Cho H. Loss of MARCH5 mitochondrial E3 ubiquitin ligase induces cellular senescence through dynamin-related protein 1 and mitofusin 1. J Cell Sci 2010, 123:619-626.
95. Ferree A.W., Trudeau K., Zik E., Benador I.Y., Twig G., Gottlieb R.A., Shirihai O.S. MitoTimer probe reveals the impact of autophagy, fusion, and motility on subcellular distribution of young and old mitochondrial protein and on relative mitochondrial protein age. Autophagy. 2013, 9:1887-1896.
96. Giedt R.J., Yang C., Zweier J.L., Matzavinos A., Alevriadou B.R. Mitochondrial fission in endothelial cells after simulated ischemia/reperfusion: role of nitric oxide and reactive oxygen species. Free Radic Biol Med 2012, 52:348-356.
97. Figge M.T., Reichert A.S., Meyer-Hermann M., Osiewacz H.D. Deceleration of fusion-fission cycles improves mitochondrial quality control during aging. PLoS Comput Biol 2012, 8:e1002576.
98. Johnson D., Allman E., Nehrke K. Regulation of acid-base transporters by reactive oxygen species following mitochondrial fragmentation. Am J Physiol Cell Physiol 2012, 302:C1045-C1054.
99. Wohlgemuth S.E., Seo A.Y., Marzetti E., Lees H.A., Leeuwenburgh C. Skeletal muscle autophagy and apoptosis during aging: effects of calorie restriction and life-long exercise. Exp Gerontol 2010, 45:138-148.
100. Dutta D., Calvani R., Bernabei R., Leeuwenburgh C., Marzetti E. Contribution of impaired mitochondrial autophagy to cardiac aging: mechanisms and therapeutic opportunities. Circ Res 2012, 110:1125-1138.
101. Joseph A.M., Adhihetty P.J., Wawrzyniak N.R., Wohlgemuth S.E., Picca A., Kujoth G.C., et al. Dysregulation of mitochondrial quality control processes contribute to sarcopenia in a mouse model of premature aging. PLoS One 2013, 8:e69327.
102. Dorn G.W. Nix nought nothing: fairy tale or real deal. J Mol Cell Cardiol. 2011, 51:497-500.
103. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 2010, 11:45-51.
104. Lee Y., Lee H.Y., Hanna R.A., Gustafsson A.B. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol 2011, 301:H1924-H1931.
105. Dorn G.W., Kirshenbaum L.A. Cardiac reanimation: targeting cardiomyocyte death by BNIP3 and NIX/BNIP3L. Oncogene 2008, 27(Suppl. 1):S158-S167.
106. Dhingra R., Margulets V., Chowdhury S.R., Thliveris J., Jassal D., Fernyhough P., et al. Bnip3 mediates doxorubicin-induced cardiac myocyte necrosis and mortality through changes in mitochondrial signaling. Proc Natl Acad Sci U S A 2014, 111:E5537-E5544.
107. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a Parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
108. Jin S.M., Youle R.J. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 2013, 9:1750-1757.